Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-039715

Chief Executive Officer sold 6,400 shares at an average $39.60 ($253,425)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-06-26 Sale −2,700 $40.01 $108,027 159,778 I
Ciechanover Isaac E. Chief Executive Officer 2018-06-26 Sale −1,700 $40.79 $69,343 158,078 I
Ciechanover Isaac E. Chief Executive Officer 2018-06-27 Sale −1,500 $37.57 $56,355 156,578 I
Ciechanover Isaac E. Chief Executive Officer 2018-06-27 Sale −500 $39.40 $19,700 156,078 I
Open-market sales · 6,400 sh · avg $39.60 · $253,425
Loading xslF345X03/doc4.xml…